APA (7th ed.) Citation

X, P., J, L., B, Z., J, Z., TS, K. M., K, N., . . . L, W. (2024). Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: Post hoc analyses from ARCHER 1050. Future oncology (London, England), 20(37), 2971. https://doi.org/10.1080/14796694.2024.2404762

Chicago Style (17th ed.) Citation

X, Pu, et al. "Efficacy in Patients with EGFR-positive Non-small-cell Lung Cancer Treated with Dacomitinib Who Had Skin Adverse Events: Post Hoc Analyses from ARCHER 1050." Future Oncology (London, England) 20, no. 37 (2024): 2971. https://doi.org/10.1080/14796694.2024.2404762.

MLA (9th ed.) Citation

X, Pu, et al. "Efficacy in Patients with EGFR-positive Non-small-cell Lung Cancer Treated with Dacomitinib Who Had Skin Adverse Events: Post Hoc Analyses from ARCHER 1050." Future Oncology (London, England), vol. 20, no. 37, 2024, p. 2971, https://doi.org/10.1080/14796694.2024.2404762.